The type 2 diabetes drug metformin can help prevent, and in some cases reverse, weight gain in youth taking second-generation antipsychotics (SGAs) for BD, according to short-term data from a large-scale trial.
The type 2 diabetes drug metformin can help prevent, and in some cases reverse, weight gain in youth taking second-generation antipsychotics (SGAs) for BD, according to short-term data from a large-scale trial.
A pharmacokinetics study of AD04, a potential treatment for AUD, is designed to meet an FDA requirement for an upcoming phase 3 trial and is expected to last 6 months.
A pharmacokinetics study of AD04, a potential treatment for AUD, is designed to meet an FDA requirement for an upcoming phase 3 trial and is expected to last 6 months.
A poster recently presented at NEI Congress 2023 suggests the use of aripiprazole lauroxil (AL), an LAI atypical antipsychotic for schizophrenia, as a versatile option supported by its pharmacokinetic, efficacy, and safety characteristics.
A poster recently presented at NEI Congress 2023 suggests the use of aripiprazole lauroxil (AL), an LAI atypical antipsychotic for schizophrenia, as a versatile option supported by its pharmacokinetic, efficacy, and safety characteristics.
Financial and insurance restrictions appear to deter some patients from filling buprenorphine prescriptions, according to a poster presented at the RX and Illicit Drug Summit.
Financial and insurance restrictions appear to deter some patients from filling buprenorphine prescriptions, according to a poster presented at the RX and Illicit Drug Summit.
